- Home
- DXCM vs CAH Comparison
DXCM vs CAH Comparison
Compare DXCM & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- CAH
- Stock Information
- Founded
- DXCM 1999
- CAH 1979
- Country
- DXCM United States
- CAH United States
- Employees
- DXCM N/A
- CAH N/A
- Industry
- DXCM Medical/Dental Instruments
- CAH Other Pharmaceuticals
- Sector
- DXCM Health Care
- CAH Health Care
- Exchange
- DXCM Nasdaq
- CAH Nasdaq
- Market Cap
- DXCM 35.7B
- CAH 29.6B
- IPO Year
- DXCM 2005
- CAH N/A
- Fundamental
- Price
- DXCM $88.78
- CAH $127.09
- Analyst Decision
- DXCM Strong Buy
- CAH Buy
- Analyst Count
- DXCM 17
- CAH 14
- Target Price
- DXCM $99.06
- CAH $136.36
- AVG Volume (30 Days)
- DXCM 3.4M
- CAH 2.6M
- Earning Date
- DXCM 02-13-2025
- CAH 01-30-2025
- Dividend Yield
- DXCM N/A
- CAH 1.59%
- EPS Growth
- DXCM 9.35
- CAH 92.22
- EPS
- DXCM 1.42
- CAH 5.36
- Revenue
- DXCM $4,033,000,000.00
- CAH $222,276,000,000.00
- Revenue This Year
- DXCM $16.44
- CAH N/A
- Revenue Next Year
- DXCM $15.78
- CAH $8.63
- P/E Ratio
- DXCM $62.34
- CAH $23.69
- Revenue Growth
- DXCM 11.34
- CAH 2.91
- 52 Week Low
- DXCM $62.34
- CAH $93.17
- 52 Week High
- DXCM $142.00
- CAH $132.84
- Technical
- Relative Strength Index (RSI)
- DXCM 57.72
- CAH 54.73
- Support Level
- DXCM $83.20
- CAH $123.94
- Resistance Level
- DXCM $93.25
- CAH $130.53
- Average True Range (ATR)
- DXCM 2.20
- CAH 2.28
- MACD
- DXCM -0.09
- CAH -0.27
- Stochastic Oscillator
- DXCM 55.52
- CAH 54.25
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.